| Authors: |
Jayaram A; University College London Cancer Institute, London, UK., Wingate A; University College London Cancer Institute, London, UK., Wetterskog D; University College London Cancer Institute, London, UK., Wheeler G; University College London Cancer Institute, London, UK., Sternberg CN; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York-Presbyterian, New York, USA., Jones R; University of Glasgow, The Beatson West of Scotland Cancer Centre, Glasgow, UK., Berruti A; University of Brescia, Spedali Civili Hospital, Brescia, Italy., Lefresne F; Janssen-Cilag, France., Lahaye M; Janssen-Cilag, France., Thomas S; Janssen Research and Development, LLC, Spring House, Pennsylvania, USA., Gormley M; Janssen Research and Development, LLC, Spring House, Pennsylvania, USA., Meacham F; Resolution BioScience, Inc., Kirkland, USA., Garg K; Resolution BioScience, Inc., Kirkland, USA., Lim LP; Resolution BioScience, Inc., Kirkland, USA., Merseburger AS; Department of Urology, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany., Tombal B; Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium., Ricci D; Janssen Research and Development, LLC, Spring House, Pennsylvania, USA., Attard G; University College London Cancer Institute, London, UK. Electronic address: g.attard@ucl.ac.uk. |
